カテゴリー： GlobalData, 世界, 医療/バイオ

神経膠肉腫：グローバル臨床試験レビュー（2021年下半期）

【英語タイトル】Gliosarcoma - Global Clinical Trials Review, H2, 2021

GlobalDataが出版した調査資料（GD21OC049）・商品コード：GD21OC049
・発行会社（調査会社）：GlobalData
・発行日：2021年8月27日
・ページ数：263
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥325,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD5,000 ⇒換算￥650,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD7,500 ⇒換算￥975,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
GlobalData臨床試験レポートの対象範囲
地域別の臨床試験
国別の臨床試験・平均登録
アジア太平洋地域での臨床試験に貢献している上位5か国
ヨーロッパでの臨床試験に貢献している上位5か国
北米での臨床試験に貢献している上位の国
中東・アフリカでの臨床試験に貢献している上位の国
中南米の臨床試験に貢献している上位の国
G7諸国による臨床試験：腫瘍学臨床試験に対する神経膠肉腫の割合
G7諸国におけるフェーズ別の臨床試験
治験状況別のG7諸国における臨床試験
E7諸国による臨床試験：腫瘍学臨床試験に対する神経膠肉腫の割合
E7諸国におけるフェーズ別の臨床試験
治験状況別のE7諸国での臨床試験
フェーズ別の臨床試験
フェーズ別の進行中の試験
試験状況別の臨床試験
エンドポイントステータスによる臨床試験
一定期間にわたって募集された被験者
主要スポンサー
神経膠肉腫治療の臨床試験に参加しているトップ企業
主要医薬品
臨床試験プロファイルのスナップショット
❖ レポートの概要 ❖

Gliosarcoma – Global Clinical Trials Review, H2, 2021
Summary

GlobalData’s clinical trial report, “Gliosarcoma – Global Clinical Trials Review, H2, 2021″ provides an overview of Gliosarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Gliosarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma – Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

❖ レポートの目次 ❖

Table of Contents
List of Tables
List of Figures
Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Gliosarcoma to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Gliosarcoma to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Gliosarcoma Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Gliosarcoma Therapeutics, Global, Clinical Trials by Region, 2021*
Gliosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
Gliosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
Gliosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2021*
Gliosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2021*
Gliosarcoma Therapeutics Clinical Trials, North America, Top Countries, 2021*
Gliosarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2021*
Gliosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2021*
Proportion of Gliosarcoma to Oncology Clinical Trials, G7 Countries (%), 2021*
Gliosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
Gliosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
Proportion of Gliosarcoma to Oncology Clinical Trials, E7 Countries (%), 2021*
Gliosarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
Gliosarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
Gliosarcoma Therapeutics, Global, Clinical Trials by Phase, 2021*
Gliosarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2021*
Gliosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2021*
Gliosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2021*
Gliosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2016-2020
Gliosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2021*
Gliosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
Gliosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
Gliosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*

List of Figures
Gliosarcoma Therapeutics, Global, Clinical Trials by Region (%), 2021*
Gliosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
Gliosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
Gliosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2021*
Gliosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2021*
Gliosarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2021*
Gliosarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2021*
Gliosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2021*
Proportion of Gliosarcoma to Oncology Clinical Trials, G7 Countries (%), 2021*
Gliosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
Gliosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
Proportion of Gliosarcoma to Oncology Clinical Trials, E7 Countries (%), 2021*
Gliosarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
Gliosarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
Gliosarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2021*
Gliosarcoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2021*
Gliosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2021*
Gliosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2021*
Gliosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2016-2020
Gliosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2021*
Gliosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
Gliosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
Gliosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*
GlobalData Methodology

★調査レポート[神経膠肉腫：グローバル臨床試験レビュー（2021年下半期）] (コード：GD21OC049)販売に関する免責事項を必ずご確認ください。
★調査レポート[神経膠肉腫：グローバル臨床試験レビュー（2021年下半期）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 髄芽腫：グローバル臨床試験レビュー（2021年下半期）
    GD21OC039 / GlobalData / 2021年7月15日 / GlobalData臨床試験レポートの対象範囲 地域別の臨床試験 国別の臨床試験・平均登録 アジア太平洋地域での臨床試験に貢献している上位5か国 ヨーロッパでの臨床試験に貢献している上位5か国...
  • 血管肉腫：グローバル臨床試験レビュー（2021年下半期）
    GD21OC076 / GlobalData / 2021年9月23日 / GlobalData臨床試験レポートの対象範囲 地域別の臨床試験 国別の臨床試験・平均登録 アジア太平洋地域での臨床試験に貢献している上位5か国 ヨーロッパでの臨床試験に貢献している上位5か国...
  • 神経膠腫：グローバル臨床試験レビュー（2021年下半期）
    GD21OC046 / GlobalData / 2021年8月27日 / GlobalData臨床試験レポートの対象範囲 地域別の臨床試験 国別の臨床試験・平均登録 アジア太平洋地域での臨床試験に貢献している上位5か国 ヨーロッパでの臨床試験に貢献している上位5か国...
  • 乏突起膠腫：グローバル臨床試験レビュー（2021年下半期）
    GD21OC043 / GlobalData / 2021年7月16日 / GlobalData臨床試験レポートの対象範囲 地域別の臨床試験 国別の臨床試験・平均登録 アジア太平洋地域での臨床試験に貢献している上位5か国 ヨーロッパでの臨床試験に貢献している上位5か国...
  • 膣がん：グローバル臨床試験レビュー（2021年下半期）
    GD21OC080 / GlobalData / 2021年9月23日 / GlobalData臨床試験レポートの対象範囲 地域別の臨床試験 国別の臨床試験・平均登録 アジア太平洋地域での臨床試験に貢献している上位5か国 ヨーロッパでの臨床試験に貢献している上位5か国...

    • ◆H&Iグローバルリサーチのお客様（例）◆